News & Events


Join us in Congratulating Both Our CEO & VP on PharmaVoice 100 Wins

Join us in Congratulating Both Our CEO & VP on PharmaVoice 100 Wins
04 August 2017

What does it take to inspire innovation in clinical trials?

Our CEO, Steve Powell, and vice president for strategic development, Etienne Drouet, are being recognized as honorees in the PharmaVOICE 100 for:

A commitment to “technology innovation” and “desire to progress healthcare opportunities for all, however distant an individual is from the treatment room.”

“A passion for unraveling and translating complex data into carefully crafted operational solutions” and getting “at the root cause of issues others might miss.”

Please join us in congratulating them and all of the 2017 members of the PharmaVOICE 100 for their dedication and contributions to the life sciences field!

This year marks the fifth time that Synteract executives have made the list, recognizing the most inspiring people in the industry. We credit our employees’ dedication to furthering our role as a leading international CRO, committed to innovation and leveraging technology to advance clinical trials to improve the lives of patients. With our sponsors having direct access to leaders like Etienne Drouet (in oncology, immunotherapy and gene therapy) and our dedicated employees--our win is your win.

Please see the full press release on these recent wins. Contact us to let us know how we can help you.


Contact Synteract

Tell us how to stay in touch with you: